Production (Stage)
Fideicomiso Irrevocable F/2061 Fhipo
BNZIF
$0.4683
-$0.0828-15.02%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 48.41M | 50.18M | 63.38M | 68.07M | 67.54M |
| Total Revenue | 48.41M | 50.18M | 63.38M | 68.07M | 67.54M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 48.41M | 50.18M | 63.38M | 68.07M | 67.54M |
| SG&A Expenses | 23.48M | 24.05M | 23.83M | 24.19M | 22.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 676.10K | -1.88M | 2.11M | -310.90K | -1.93M |
| Total Operating Expenses | 24.16M | 22.16M | 25.95M | 23.88M | 21.03M |
| Operating Income | 24.25M | 28.02M | 37.43M | 44.19M | 46.50M |
| Income Before Tax | 24.87M | 28.64M | 37.53M | 44.29M | 46.60M |
| Income Tax Expenses | -49.60K | 16.20K | 116.80K | 189.30K | 199.80K |
| Earnings from Continuing Operations | 24.92 | 28.63 | 37.42 | 44.10 | 46.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.92M | 28.63M | 37.42M | 44.10M | 46.40M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.12 | 0.13 | 0.19 | 0.22 | 0.23 |
| Normalized Basic EPS | 0.07 | 0.08 | 0.12 | 0.14 | 0.14 |
| EPS Diluted | 0.12 | 0.13 | 0.19 | 0.22 | 0.23 |
| Normalized Diluted EPS | 0.07 | 0.08 | 0.12 | 0.14 | 0.14 |
| Average Basic Shares Outstanding | 827.54M | 833.10M | 838.66M | 847.42M | 854.60M |
| Average Diluted Shares Outstanding | 827.54M | 833.10M | 838.66M | 847.42M | 854.60M |
| Dividend Per Share | 0.07 | 0.07 | 0.09 | 0.11 | 0.12 |
| Payout Ratio | 103.60% | 120.75% | 109.62% | 100.42% | 90.51% |